Literature DB >> 7665578

Stat5 as a target for regulation by extracellular matrix.

C H Streuli1, G M Edwards, M Delcommenne, C B Whitelaw, T G Burdon, C Schindler, C J Watson.   

Abstract

Transcription of tissue-specific genes in mammary gland requires signals from both prolactin and basement membrane. Here we address the mechanism by which this specialized extracellular matrix regulates transcription. Using mammary cell cultures derived from transgenic mice harboring the ovine beta-lactoglobulin gene, we show that either a basement membrane extract, or purified laminin-1, induced high levels of beta-lactoglobulin synthesis. It is known that prolactin signals through Stat5 (signal transducer and activator of transcription). This transcription factor interacts with gamma-interferon activation site-related motifs within the beta-lactoglobulin promoter, which we show are required for matrix dependence of beta-lactoglobulin expression. The DNA binding activity of Stat5 was present only in extracts of mammary cells cultured on basement membrane, indicating that the activation state of Stat5 is regulated by the type of substratum the cell encounters. Thus, basement membrane controls transcription of milk protein genes through the Stat5-mediated prolactin signaling pathway, providing a molecular explanation for previous studies implicating extracellular matrix in the control of mammary differentiation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7665578     DOI: 10.1074/jbc.270.37.21639

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  Integrin-mediated adhesion of endothelial cells induces JAK2 and STAT5A activation: role in the control of c-fos gene expression.

Authors:  M F Brizzi; P Defilippi; A Rosso; M Venturino; G Garbarino; A Miyajima; L Silengo; G Tarone; L Pegoraro
Journal:  Mol Biol Cell       Date:  1999-10       Impact factor: 4.138

2.  Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3.

Authors:  R S Chapman; P C Lourenco; E Tonner; D J Flint; S Selbert; K Takeda; S Akira; A R Clarke; C J Watson
Journal:  Genes Dev       Date:  1999-10-01       Impact factor: 11.361

Review 3.  Control of normal mammary epithelial phenotype by integrins.

Authors:  C H Streuli; G M Edwards
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-04       Impact factor: 2.673

Review 4.  Cell nucleus in context.

Authors:  S A Lelièvre; M J Bissell; P Pujuguet
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2000       Impact factor: 1.807

Review 5.  Tissue architecture: the ultimate regulator of breast epithelial function.

Authors:  Mina J Bissell; Aylin Rizki; I Saira Mian
Journal:  Curr Opin Cell Biol       Date:  2003-12       Impact factor: 8.382

Review 6.  The Nuclear Factor I (NFI) gene family in mammary gland development and function.

Authors:  Janice Murtagh; Finian Martin; Richard M Gronostajski
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

Review 7.  Integrins in mammary gland development and differentiation of mammary epithelium.

Authors:  Ilaria Taddei; Marisa M Faraldo; Jérôme Teulière; Marie-Ange Deugnier; Jean Paul Thiery; Marina A Glukhova
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-10       Impact factor: 2.673

8.  Function following form: functional differentiation of mammary epithelial cells requires laminin-induced polarization of PI3-kinase.

Authors:  Derek C Radisky
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

9.  Laminin regulates PI3K basal localization and activation to sustain STAT5 activation.

Authors:  Ren Xu; Virginia A Spencer; Dinah Levy Groesser; Mina J Bissell
Journal:  Cell Cycle       Date:  2010-11-10       Impact factor: 4.534

Review 10.  Integrated extracellular matrix signaling in mammary gland development and breast cancer progression.

Authors:  Jieqing Zhu; Gaofeng Xiong; Christine Trinkle; Ren Xu
Journal:  Histol Histopathol       Date:  2014-03-28       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.